Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 799 results for "sandoz inc"

Supreme Court Hears Arguments on Appellate Standard of Review ...

The United States Supreme Court heard oral argument October 15, 2014, in Teva Pharm. USA, Inc. v. Sandoz, Inc. , No. 13-854. (The transcript and audio recording are available here .) The question before the Court in this case is whether the Federal ... JD Supra, 4 days ago

2 images for "sandoz inc"

Talk Radio News Service, 1 week ago
Reuters UK, 1 week ago
Reuters

Supreme Court divided in battle over Teva MS drug patent

Carter Phillips (R) of the Sidley Austin firm representing Mylan Inc in the case of Teva Pharmaceuticals USA v. Sandoz, departs after arguments at the U.S. Supreme Court, October 15, 2014. Credit: Reuters/Jonathan Ernst (Reuters) - The ...
 Reuters1 week ago Questions in Teva case divides Supreme Court justices in oral arguments  Inside Counsel1 week ago U.S. Supreme Court divided on Teva patent dispute  Haaretz1 week ago Supreme Court weighs generic drug dispute  Yahoo! Singapore1 week ago
[x]  

United Therapeutics Corp. v. Sandoz, Inc.

Case Name: , Civ. Nos. 12-cv-01617, 13-cv-316, 2014 U.S. Dist. LEXIS 121573 (D.N.J. Aug. 29, 2014) (Sheridan, J.) Drug Product and Patent(s)-in-Suit: Remodulin® (treprostinil sodium); U.S. Patents Nos. 6,576,117 (the 117 patent) and 7,999,007 ...
 JD Supra3 days ago Hospira, Inc. v. Burwell  JD Supra5 days ago

Novartis AG's Sandoz, Inc. Will Move Into Former Novo Nordisk A/S Headquarters In New Jersey

PLAINSBORO — The former home of Novo Nordisk, a Danish pharmaceutical company that has sat vacant along Route 1 for more than a year, will soon have a new tenant and new job opportunities. Sandoz Inc., a major pharmaceutical company that ...
 BioSpace3 weeks ago

Novartis : CONTRACT AWARD - 65-- Oxazepam Capsules Sandoz, Inc Effective: 9/22/2014 - 9/21/2015 (+ 4 one year options)

Notice Type: CONTRACT AWARD Posted Date: 12-SEP-14 Office: VA National Acquisition Center Location: DEPARTMENT OF VETERANS AFFAIRS NATIONAL ACQUISITION CENTER Office Address: DEPARTMENT OF VETERANS AFFAIRS , VA NATIONAL ACQUISITION ...
 4 Traders1 month ago

PharmaDerm launches onychomycosis medication in US

PharmaDerm, a dermatology business of Sandoz, has launched KERYDIN topical solution, 5%, for the treatment of onychomycosis of the toenails, in US. KERYDIN is developed by Anacor Pharmaceuticals, Inc. In July 2014, Sandoz announced an agreement with ...
 Individual.com4 weeks ago Anacor's Kerydin Launched in the US for Onychomycosis  Yahoo! Finance1 month ago Anacor Announces U.S. Launch Of KERYDIN Topical Solution, 5%  RTTNews.com1 month ago

Momenta Reveals Necuparanib Data for Pancreatic Cancer

Momenta Pharmaceuticals, Inc. ( MNTA ) announced top-line results from the part A portion of a phase I/II study evaluating necuparanib for the treatment of advanced metastatic pancreatic cancer. In the part A portion of the study, patients were ...
 Yahoo! Finance2 weeks ago
[x]  

UPDATE 1-Amgen's Humira copy succeeds in skin disease trial

(Adds analyst comment, background; updates shares) Oct 8 (Reuters) - Amgen Inc said its copycat version of AbbVie Inc's blockbuster biotech drug Humira showed comparable safety and ability to generate immune response in patients with a type of ...
 CNBC2 weeks ago Amgen's Humira Copy Succeeds in Plaque Psoriasis Trial  General Medicine eJournal2 weeks ago Amgen's Humira copy succeeds in skin disease trial  Reuters India2 weeks ago
[x]  

Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application for RayVa(TM)

SAN DIEGO, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced that the United States Patent and Trademark Office ...
 BizWire Express1 week ago Apricus Biosciences, Inc. (APRI) Developing Novel Health Solutions  InvestorIdeas.com3 weeks ago Apricus Biosciences To Present At The 13th Annual BIO Investor Forum  TheStreet.com3 weeks ago APRICUS BIOSCIENCES : Announces Notice of Allowance of U.S. Patent Application for RayVa(TM)  4 Traders1 week ago
[x]  

Anacor Pharmaceuticals, Inc. Announces Proposed Offering of $70 Million of Convertible Senior Notes Due 2021

Anacor Pharmaceuticals, Inc. ( NASDAQ:ANAC ) announced today that it intends to offer, subject to market and other considerations, $70,000,000 aggregate principal amount of Convertible Senior Notes due 2021 (the Convertible ...
 Street Sweeper2 weeks ago Anacor Pharmaceuticals Inc. Announces Proposed Offering of $70 Million of Convertible Senior Notes Due 2021  PharmiWeb2 weeks ago Anacor Pharmaceuticals Announces Commercial Launch of KERYDIN (tavaborole) Topical Solution, 5% in the United States  Street Sweeper1 month ago ANACOR PHARMACEUTICALS : Announces Commercial Launch of KERYDIN (tavaborole) Topical Solution, 5% in the United States  4 Traders1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less